Pharmerica (PMC) Tops Q2 EPS by 4c

PharMerica Reports Second Quarter 2015 Results

August 7, 2015 8:00 AM EDT

Solid Year Over Year Improvement in Revenue and Adjusted EBITDA

Industry Leading Generic Dispensing Rate Increases To Record 86%

Reaffirms Annual 2015 Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2015.

            2Q15 Results        

Comparison to

2Q14

        Comparison to

1Q15

Revenue         $497.5 million         Increase of 10.9%         Decrease of 2.8% Adjusted EBITDA         $33.2 million        ... More